[Application of modified ultrafiltration in infants undergoing cardiac surgery with cardiopulmonary bypass]

Wei Cheng1, Ying-Bin Xiao, Qian-Jin Zhong

  • 1Department of Cardiovascular Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China.

Insights

Modified ultrafiltration (MUF) reduces postoperative bleeding and transfusion needs in infants undergoing cardiac surgery with cardiopulmonary bypass (CPB). This technique also improves pulmonary function and shortens mechanical ventilation duration.

Area of Science:

  • Pediatric Cardiac Surgery
  • Cardiopulmonary Bypass (CPB)
  • Ultrafiltration Techniques

Context:

  • Infants undergoing cardiac surgery with CPB face significant postoperative complications.
  • Assessing novel techniques to mitigate these risks is crucial for improving patient outcomes.

Purpose:

  • To evaluate the efficacy of a modified ultrafiltration (MUF) technique in infants undergoing cardiac surgery with CPB.
  • To compare postoperative outcomes between infants receiving MUF and a control group.

Summary:

  • A randomized controlled trial involving 261 infants (<1 year) compared MUF during CPB (n=205) versus no MUF (n=56).
  • The MUF group showed significantly reduced postoperative blood loss (79.5 vs. 57.3 mL) and transfusion requirements (78.1 vs. 67.9 mL).
  • MUF also led to shorter mechanical ventilation duration (28.6 vs. 32.3 hrs), improved hematocrit (34.6% vs. 29.8%), and enhanced oxygenation index (275.2 vs. 202.2) 24 hours postoperatively.

Impact:

  • MUF offers a safe and effective method to minimize complications in pediatric cardiac surgery.
  • Improved pulmonary function and reduced reliance on mechanical ventilation can lead to faster recovery.
  • This technique holds promise for enhancing the management of infants undergoing complex cardiac procedures.
Abstract

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...